Medical News

RSS

Researchers discover drug that halts growth of brain tumor cells

Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of - and ultimately left no detectable trace of - brain tumor cells taken from adult human patients.

24 Sep 2013

Researchers reveals key role for stem cells that promote inflammation in atherosclerosis

University at Buffalo translational researchers are developing a richer understanding of atherosclerosis in humans, revealing a key role for stem cells that promote inflammation.

24 Sep 2013

Addition of walnuts to diet can protect against diabetes and heart disease in at-risk individuals

Medical researchers from the Yale-Griffin Prevention Research Center in Connecticut have found evidence suggestive that adding walnuts to one's diet can protect against diabetes and heart disease in at-risk individuals.

24 Sep 2013

Clean water and growth of children: an interview with Dr Alan Dangour

Growth in children is known to be directly affected by two critical factors: food intake and incidence of disease. It is known that access to good quality water, improved sanitation and enhanced hygiene (WASH) practices lead to decreased levels of infectious disease in children. We were interested to know whether this decline in disease would lead to improvements in child growth.

23 Sep 2013

Mild COPD phenotype discovery offers treatment hope

Research indicates that smokers with and without mild chronic obstructive pulmonary disease can be classified into distinct phenotypes on the basis of computed tomography findings.

23 Sep 2013

QoL questionnaire predicts nocturia, risk for falling

A study of Japanese outpatients highlights the association between nighttime voiding and bone fractures, after showing that the Nocturia Quality-of-Life questionnaire can identify patients at risk for both.

23 Sep 2013

Surgery shows first-line potential for stress urinary incontinence

The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.

23 Sep 2013

Sleep disturbances may influence vascular cognitive decline

Patients with vascular cognitive impairment without dementia have distinct abnormal sleep patterns that may be related to their cognitive deficits, researchers report.

23 Sep 2013

Genes play meaningful role in sleep quality

Researchers have quantified the contribution genetics makes to sleep quality variation in a twin study of middle-aged men.

23 Sep 2013

Framingham model predicts hypertension in young adults

The Framingham Heart Study model for predicting short-term risk for hypertension has good discriminatory ability in a biracial population of young adults, say researchers.

23 Sep 2013

Urinary pneumococcal antigen testing ‘useful in children’

Urinary antigen testing is effective in detecting invasive pneumococcal pneumonia in children, say the authors of a UK-based case–control study.

23 Sep 2013

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

23 Sep 2013

Karo Bio, 4D Science Team Up On Treatments For Fibrotic Diseases

...

23 Sep 2013

Abbvie, Ablynx Ink Up To $840M RA, SLE Collaboration

...

23 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Plenary sessions at AdvaMed 2013 conference to explore new Medicare payment initiatives

The second day of AdvaMed 2013: The MedTech Conference at the Walter E. Washington Convention Center in Washington, D.C., will feature plenary sessions honoring two of the industry's congressional champions and exploring the impact of new Medicare payment initiatives on patient access to medical innovations.

23 Sep 2013

Biosafe expands its stem cell banking business in India

Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively.

23 Sep 2013

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.

23 Sep 2013

Advamed 2013 conference to focus on global opportunities and challenges in medical technology industry

AdvaMed 2013: The MedTech Conference begins today at the Walter E. Washington Convention Center in Washington, D.C. with a major emphasis on the opportunities and challenges facing the medical technology industry in an increasingly global marketplace.

23 Sep 2013

HTA acquires 6 on-campus medical office buildings in South Florida

Healthcare Trust of America, Inc. "HTA") today announced it had acquired 6 on-campus medical office buildings ("MOB") located in South Florida for approximately $63 million.

23 Sep 2013